NCT03126409Active, not recruiting
No-Touch Versus Conventional Saphenous Vein Harvesting Technique
A Multicenter Randomized Trial to Compare the Graft Patency Between No-Touch Vein Harvesting Technique and Conventional Approach in Coronary Artery Bypass Graft Surgery: the PATENCY Study
Source: ClinicalTrials.gov · Last updated 4 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study evaluates the short-term patency of vein graft harvested by the No-Touch technique compared to that by the conventional approach in patients undergoing isolated on-pump/off-pump coronary artery bypass graft (CABG) surgery. a total of at least 2000 patients undergoing isolated on-pump/off-pump CABG will be consecutively recruited from 7 hospitals across China and randomly assigned to receive No-Touch saphenous vein harvesting or conventional approach. All participants will be invited for clinical follow-up and 64-slice multislice computed tomography angiography (MSCTA) analysis at 3 months post-operatively.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 2655 (actual)
- First submitted
- 19 Apr 2017
- Start date
- 14 May 2017
- Primary completion date
- 30 Dec 2029
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Diseases
- Coronary artery disease
- NCT number
- NCT03126409
What you commit to
- Study type: Interventional
- Participants enrolled: 2655
- From 14 May 2017 to the primary completion date, 30 Dec 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Need for a concomitant cardiac or vascular surgeries (i.e. valve repair or replacement, Maze surgery)
- Endarterectomy of coronary artery during surgery
Other illness
- Combined with malignant tumor or other severe systemic conditions
- Contraindications for dual antiplatelet therapy, such as active gastroduodenal ulcer
Lab values
- Severe renal insufficiency (i.e. creatinine \>200 μmol/L)
Other
- Redo-CABG
- Emergent CABG
- Using vascular stapler for anastomosis
- Left ventricular repair due to ventricular aneurysm
- Participants of another ongoing clinical trials
Who the study is looking for
- Patients receiving first time isolated on-pump/off-pump CABG
- Patients with at least one available saphenous vein graft
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fuwai Hospital Chinese Academay of Medical Science and National Center for Cardiovascular Diseases Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.